|
Market Closed -
Nasdaq Stockholm
09:30:00 17/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 6.340 SEK | -0.16% |
|
-8.78% | +13.21% |
| 16/09 | Mendus Launches Early-stage Trial for Acute Myeloid Leukemia Treatment Combo | MT |
| 16/09 | Mendus launches Phase 1b study with vididencel | FW |
| Market Cap | 42Cr 4.28Cr 3.73Cr 3.53Cr 3.21Cr 5.99Cr 410.09Cr 6.02Cr 16Cr 208.41Cr 16Cr 16Cr 667.18Cr | P/E 2026 * |
-4.17x | P/E 2027 * | -6.34x |
|---|---|---|---|---|---|
| Enterprise Value | 44Cr 4.5Cr 3.92Cr 3.71Cr 3.37Cr 6.3Cr 430.88Cr 6.33Cr 17Cr 218.98Cr 17Cr 17Cr 701Cr | EV / Sales 2026 * |
57.9x | EV / Sales 2027 * | 1.44x |
| Free-Float |
34.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IMMU | Delayed | |
Deutsche Boerse AG
| 1YG0 | Delayed | |
|
CBOE
| Real-time | ||
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| 1YG0 | Delayed | |
|
CBOE
| IMMUs | Real-time | |
|
Boerse Muenchen
| 1YG0 | Real-time |
Last Transcript: Mendus AB
| 1 day | -0.16% | ||
| 1 week | -8.78% | ||
| Current month | -9.43% | ||
| 1 month | -8.51% | ||
| 3 months | +15.27% | ||
| 6 months | +52.96% | ||
| Current year | +13.21% |
| 1 week | 6 |  | 7.9 |
| 1 month | 6 | | 8.49 |
| Current year | 3.86 | | 8.49 |
| 1 year | 3.86 | | 8.49 |
| 3 years | 3.86 | | 16.38 |
| 5 years | 3.86 | | 126.8 |
| 10 years | 3.86 | | 640 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Manting
CEO | Chief Executive Officer | 54 | 16/03/2021 |
| Chief Executive Officer | 76 | 13/12/2019 | |
Lotta Ferm
DFI | Director of Finance/CFO | 60 | 28/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Christine Lind
CHM | Chairman | 52 | 22/01/2021 |
Helén Tuvesson
BRD | Director/Board Member | 64 | 01/01/2020 |
| Director/Board Member | 74 | 01/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/02/22 | Buy | Chief Technology Officer | 10,000 | 0.0050% | ||
| 24/02/22 | Buy | Chief Financial Officer | 10,000 | 0.0050% | ||
| 24/02/22 | Buy | Chief Financial Officer | 10,000 | 0.0050% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.16% | -8.78% | -8.25% | -25.85% | 4.31Cr | |
| +1.23% | +1.87% | -0.15% | +28.45% | 4.59TCr | |
| -0.07% | +4.86% | +44.52% | +28.88% | 4.42TCr | |
| -0.44% | -4.06% | +345.33% | +530.78% | 4.2TCr | |
| +1.42% | +3.30% | +6.29% | +69.01% | 3.96TCr | |
| +1.75% | -1.53% | +12.22% | +41.11% | 3.11TCr | |
| -0.04% | +6.16% | +24.36% | +126.69% | 1.72TCr | |
| -3.44% | -8.46% | - | - | 1.63TCr | |
| +2.92% | +8.40% | +22.46% | +39.73% | 1.5TCr | |
| -2.16% | +2.88% | -2.71% | -35.19% | 1.34TCr | |
| Average | +0.09% | +0.02% | +49.34% | +89.29% | 2.65TCr | |
| Weighted average by Cap. | +0.39% | +0.68% | +71.69% | +125.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76.33L 8L 7L 6L 6L 10.88L 7.45Cr 10.93L 29.52L 3.78Cr 29.2L 28.56L 12Cr | 17Cr 1.75Cr 1.53Cr 1.45Cr 1.31Cr 2.45Cr 167.93Cr 2.47Cr 6.66Cr 85Cr 6.59Cr 6.44Cr 273.21Cr |
| Net income | -9.92Cr -1.01Cr -87.97L -83.26L -75.65L -1.41Cr -97Cr -1.42Cr -3.83Cr -49Cr -3.79Cr -3.71Cr -157.37Cr | -3.33Cr -33.96L -29.58L -27.99L -25.43L -47.51L -33Cr -47.75L -1.29Cr -17Cr -1.28Cr -1.25Cr -53Cr |
| Net Debt | 2.13Cr 21.71L 18.91L 17.89L 16.26L 30.37L 21Cr 30.52L 82.41L 11Cr 81.54L 79.72L 34Cr | -17Cr -1.75Cr -1.53Cr -1.44Cr -1.31Cr -2.45Cr -167.78Cr -2.46Cr -6.65Cr -85Cr -6.58Cr -6.43Cr -272.95Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | SEK 6.340 | -0.16% | 22,622 |
| 16/26/16 | SEK 6.350 | -4.37% | 51,195 |
| 15/26/15 | SEK 6.640 | -3.35% | 15,666 |
| 14/26/14 | SEK 6.870 | -4.32% | 18,620 |
| 11/26/11 | SEK 7.180 | +3.31% | 82,215 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMU Stock
Select your edition
All financial news and data tailored to specific country editions
